GigaMedia (NASDAQ:GIGM) Stock, Quote.Headers.trade-ideas

GigaMedia

GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ADES

AIHS

ALBO

AMTD

ARTL

BBBY

BLND

BZFD

CIDM

COMP

EMBK

ESOA

FFIE

FRZA

GBOX

GIGM

GLBE

GOCO

HALL

HLBZ

INKT

INTR

IONQ

ISUN

IZEA

KIRK

LIDR

MARK

MYNZ

MYSZ

NCRA

NOVA

NVTA

NVTS

POWW

PRTY

QRHC

REBN

SGHC

SKYT

SMFR

Sunlight Financial Holdings, Inc. Class A Common Stock

SUNL

SVFD

Tempest Therapeutics, Inc. - Common Stock

TPST

TRIN

TRMR

TTOO

VISL

VTYX

Gainers


	GreenBox POS  (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales.


Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday&#39;s Mid-Day Session

Pre-Market Outlook

ASTS

KSPN

MEGL

OKYO

UXIN

Gainers


	IZEA Worldwide, Inc. (NASDAQ: IZEA) shares rose 30.8% to $1.19 in pre-market trading after the company reported a second-quarter revenue increase of 96% year-over-year to $12.58 million, beating the consensus of $9.75 million.


Why IZEA Worldwide Shares Are Trading Higher By Over 30%: Here Are 37 Stocks Moving Premarket

AGFY

AKUS

APRN

ASTR

AXDX

CNTG

DAVE

DOYU

DRRX

EHAB

EMBC

FCUV

FPAY

GNPX

HLGN

HTCR

HYRE

IDYA

ILAG

ILMN

IMVT

LOGC

LTCH

LTRPB

MLTX

MyMD Pharmaceuticals, Inc. - Common Stock

MYMD

NUZE

NVIV

PLXP

POSH

PSHG

PSTV

QTEK

RCMT

RKDA

RVLP

RYTM

SMRT

SNAX

SNPX

SPRC

SRTS

TCRT

TERN

TISI

TLRY

TUEM

TYDE

VEEE

VRDN

WETG

WULF

EPOW

Gainers


	Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company&#39;s IPO earlier this month.


This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday

GigaMedia Ltd

GigaMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIGM#NASDAQ">GIGM</a>) reported quarterly losses of $(0.06) per share. This is a 20 percent decrease over losses of $(0.05) per share from the same period last year. The company reported $721.00 thousand in sales this quarter. This is a 29.66 percent decrease over sales of $1.02 million the same period last year.

Earnings

GigaMedia Q2 EPS $(0.06) Down From $(0.05) YoY, Sales $721.00K Down From $1.02M YoY

Guidance

GigaMedia CEO James Huang Says We Believe That Will Lead To A Healthier Gross Margin In The Long-run For Our Own Offerings

GigaMedia Q1 2024 Revenue $0.73M Down From $1.32M YoY

GigaMedia Appoints Chih-Hong Tsai (a.k.a. John J.H. Tsai) And Wan-Wan Lin As New Independent Non-Executive Directors Upon Departure Of Casey Kuo-Chong Tung and Billy Bing-Yuan Huang

GigaMedia CEO James Huang Says GigaMedia Will Stick To The Strategy Of Pursuing Healthy Growth With A Lean Operation While Seeking For Strategic Expansion And New Business

GigaMedia CEO James Huang Says In 2H 2023 We Will Dedicate Ourselves To Boosting The Productivity Of Our Products And Services

GigaMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIGM#NASDAQ">GIGM</a>) reported quarterly losses of $(0.05) per share. This is a 50 percent increase over losses of $(0.10) per share from the same period last year. The company reported $1.03 million in sales this quarter. This is a 24.43 percent decrease over sales of $1.36 million the same period last year.

GigaMedia Q2 EPS $(0.05) Up From $(0.10) YoY, Sales $1.03M Down From $1.36M YoY

GigaMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIGM#NASDAQ">GIGM</a>) reported quarterly losses of $(0.03) per share. This is a 130 percent decrease over earnings of $0.10 per share from the same period last year. The company reported $1.33 million in sales this quarter. This is a 14.27 percent decrease over sales of $1.55 million the same period last year.

GigaMedia Q1 EPS $(0.03) Down From $0.10 YoY, Sales $1.33M Down From $1.55M YoY

GigaMedia Q4 EPS $0.00, Sales $1.10M Down From $1.26M YoY

GigaMedia Said Will Continue Exploring Potential Strategic Investment And Acquisition Targets That Would Enable Us To Accelerate Corporate Growth And Enhance Long-term Profitability

GigaMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIGM#NASDAQ">GIGM</a>) reported quarterly losses of $(0.08) per share. This is a 14.29 percent decrease over losses of $(0.07) per share from the same period last year. The company reported $1.58 million in sales this quarter. This is a 1.02 percent increase over sales of $1.56 million the same period last year.

GigaMedia Q3 EPS $(0.08) Down From $(0.07) YoY, Sales $1.58M Up From $1.56M YoY

<h3>Gainers</h3>
<ul>
<li>GreenBox POS (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbox#NASDAQ">GBOX</a>) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales.</li>
<li>Artelo Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/artl#NASDAQ">ARTL</a>) gained 42.4% to $6.21 as the company reported pre-clinical results with its novel inhibitor to fatty acid binding protein 5.</li>
<li>My Size, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mysz#NASDAQ">MYSZ</a>) surged 41.7% to $0.3566 after the company said Q2 EPS and sales results were up year over year and issued FY22 sales guidance.</li>
<li>Forza X1, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frza#NASDAQ">FRZA</a>) shares jumped 36.3% to $8.26 amid continued volatility following Friday&#39;s IPO.</li>
<li>SkyWater Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skyt#NASDAQ">SKYT</a>) shares climbed 31.9% to $18.80 after the company reported better-than-expected Q2 sales results.</li>
<li>Kirkland&#39;s, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kirk#NASDAQ">KIRK</a>) gained 31.9% to $5.31. Kirkland&#39;s is expected to report Q2 results on Tuesday, August 30, 2022.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) surged 29.4% to $24.07 after the company reported Q2 results and announced positive data from the Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) trial of VTX958, a novel and selective allosteric TYK2 inhibitor.</li>
<li>AMTD IDEA Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amtd#NYSE">AMTD</a>) gained 29.4% to $2.9250 after AMTD Group announced it will inject into the company 100% of the equity interest in AMTD Assets Group.</li>
<li>Nocera, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncra#NASDAQ">NCRA</a>) gained 28.5% to $2.61. Nocera reported closing of $6.58 million underwritten public offering.</li>
<li>IonQ, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ionq#NYSE">IONQ</a>) rose 28.1% to $8.15 following upbeat Q2 sales.</li>
<li>Reborn Coffee, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rebn#NASDAQ">REBN</a>) jumped 27.3% to $5.08. Reborn Coffee, last week, priced its IPO at $5 per share.</li>
<li>Global-e Online Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbe#NASDAQ">GLBE</a>) gained 25% to $34.17 after the company reported better-than-expected Q2 results and issued Q3 and FY22 guidance above estimates.</li>
<li>Bed Bath &amp; Beyond Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbby#NASDAQ">BBBY</a>) surged 25% to $20.12. B. Riley Securities downgraded Bed Bath &amp; Beyond from Neutral to Sell and announced a $5 price target.</li>
<li>Eargo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ear#NASDAQ">EAR</a>) gained 21% to $1.38. The FDA finalized rule enabling access to over-the-counter hearing aids.</li>
<li>Navitas Semiconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvts#NASDAQ">NVTS</a>) rose 20.4% to $7.42 following strong quarterly results.</li>
<li>Advanced Emissions Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ades#NASDAQ">ADES</a>) jumped 20.1% to $5.89 after the company reported better-than-expected Q2 sales results.</li>
<li>Energy Services of America Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/esoa#NASDAQ">ESOA</a>) rose 19.6% to $2.85. Energy Services Of America posted Q2 earnings of $0.10 per share on sales of $51.17 million.</li>
<li>Emerson Radio Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msn#NYSE">MSN</a>) gained 19.4% to $0.8001.</li>
<li>Blend Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blnd#NYSE">BLND</a>) jumped 19.2% to $3.2912 after the company reported better-than-expected Q2 sales results and raised Title365 revenue guidance.</li>
<li>Tempest Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpst#NASDAQ">TPST</a>) gained 19% to $2.88 after the company reported a narrower Q2 loss.</li>
<li>Party City Holdco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/prty#NYSE">PRTY</a>) rose 18% to $1.8550. Party City recently reported better-than-expected Q2 EPS.</li>
<li>Quest Resource Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrhc#NASDAQ">QRHC</a>) gained 17.2% to $5.79 following upbeat quarterly sales.</li>
<li>GigaMedia Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gigm#NASDAQ">GIGM</a>) rose 16.4% to $2.7001 after jumping over 41% on Monday. GigaMedia, last month, posted a Q2 loss of $0.10 per share.</li>
<li>Nu Holdings Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nu#NYSE">NU</a>) rose 13.9% to $5.33 following strong quarterly sales.</li>
<li>IZEA Worldwide, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izea#NASDAQ">IZEA</a>) shares gained 13.8% to $1.0360 after the company reported a second-quarter revenue increase of 96% year-over-year to $12.58 million, beating the consensus of $9.75 million.</li>
<li>Embark Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/embk#NASDAQ">EMBK</a>) rose 13.4% to $0.83 after dropping around 32% on Monday. Embark Technology, last week, reported better-than-expected Q2 EPS results.</li>
<li>Fabrinet (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fn#NYSE">FN</a>) gained 12.5% to $113.30 following better-than-expected Q4 results.</li>
<li>GigaMedia Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gigm#NASDAQ">GIGM</a>) gained 11.6% to $2.59.</li>
<li>Mainz Biomed B.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mynz#NASDAQ">MYNZ</a>) jumped 10% to $10.22. Mainz Biomed and Dante Genomics announced full commercial availability of ColoAlert in Italy and the United Arab Emirates.</li>
<li>Inter &amp; Co, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intr#NASDAQ">INTR</a>) gained 8.6% to $3.80.</li>
<li>Treasure Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgl#NASDAQ">TGL</a>) shares rose 7% to $7.70 after the company reported closing of upsized $9.2 million initial public offering, Nasdaq listing, and full exercise of underwriter&rsquo;s over-allotment option.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dna#NYSE">DNA</a>) shares rose 6.2% to $3.7048 after the company said Q2 sales results were up year over year and raised FY22 sales guidance above estimates.</li>
<li>Walmart Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wmt#NYSE">WMT</a>) gained 5.7% to $140.16 as the company reported second-quarter FY23 revenue growth of 8.4% year-on-year, to $152.86 billion, beating the consensus of $150.75 billion.</li>
<li>Kohl&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kss#NYSE">KSS</a>) climbed 5.2% to $34.79. Kohl&#39;s named Christie Raymond as Chief Marketing Officer.</li>
<li>Senmiao Technology Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aihs#NASDAQ">AIHS</a>) rose 5% to $1.06 after the company posted a profit for the first quarter.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Rubicon Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rbt#NYSE">RBT</a>) dipped 38.8% to $6.00. Rubicon Technologies started trading on the NYSE today, August 16, 2022, following the completion of its business combination with Founder SPAC.</li>
<li>Save Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svfd#NASDAQ">SVFD</a>) fell 38% to $2.95 after the company priced a 1.6 million share common stock offering at $3 per share.</li>
<li>Hallmark Financial Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hall#NASDAQ">HALL</a>) shares fell 37.4% to $1.5599 after the company reported a wider Q2 loss.</li>
<li>Polished.com Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pol#NYSE">POL</a>) fell 35.8% to $0.9701. Polished.com said it sees preliminary Q2 sales of $145 million to $150 million, versus analysts&rsquo; estimates of $156.15 million.</li>
<li>GoHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goco#NASDAQ">GOCO</a>) shares fell 31.6% to $0.6052 following downbeat quarterly earnings.</li>
<li>Sema4 Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfr#NASDAQ">SMFR</a>) fell 31% to $1.6550 after the company reported a drop in Q2 sales and issued weak FY22 sales forecast.</li>
<li>Sunlight Financial Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sunl#NYSE">SUNL</a>) dropped 29.9% to $3.12 after the company reported worse-than-expected Q2 EPS and sales results.</li>
<li>T2 Biosystems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttoo#NASDAQ">TTOO</a>) shares fell 23.5% to $0.1570 after the company reported a wider Q2 loss and announced worse-than-expected sales results.</li>
<li>Albireo Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/albo#NASDAQ">ALBO</a>) dropped 23.5% to $19.00 after the company reported worse-than-expected Q2 EPS results and filed for a mixed shelf of up to $400 million.</li>
<li>Helbiz, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlbz#NASDAQ">HLBZ</a>) fell 22.1% to $1.1050. Helbiz posted a Q2 loss of $0.57 per share.</li>
<li>iSun, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/isun#NASDAQ">ISUN</a>) fell 21.9% to $3.8201 as the company posted a wider loss for its second quarter.</li>
<li>MiNK Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inkt#NASDAQ">INKT</a>) fell 21.5% to $2.6691 after gaining 99% on Monday.</li>
<li>Tremor International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trmr#NASDAQ">TRMR</a>) fell 21.3% to $8.19 after the company reported worse-than-expected Q2 results.</li>
<li>GAN Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gan#NASDAQ">GAN</a>) fell 20.3% to $3.46 after the company reported worse-than-expected Q2 sales results and issued FY22 sales guidance below estimates.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffie#NASDAQ">FFIE</a>) dipped 20% to $2.2300 after Benchmark downgraded the stock from Buy to Speculative Hold. Faraday Future reported an operating loss of $137 million during the three months ended June 30, 2022.</li>
<li>TOP Financial Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/top#NASDAQ">TOP</a>) fell 18.4% to $10.80.</li>
<li>AMMO, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/poww#NASDAQ">POWW</a>) dropped 17% to $4.48 after the company reported worse-than-expected Q1 sales.</li>
<li>Zomedica Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zom#NYSE">ZOM</a>) fell 16.8% to $0.3070. Zomedica Pharmaceuticals posted a Q2 loss of $0.01 per share.</li>
<li>Remark Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mark#NASDAQ">MARK</a>) shares fell 15.7% to $0.4551 after posting downbeat quarterly sales.</li>
<li>AEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lidr#NASDAQ">LIDR</a>) dropped 15.6% to $2.49. AEye recently reported better-than-expected Q2 EPS results.</li>
<li>Sea Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/se#NYSE">SE</a>) fell 13.5% to $77.84 after the company reported worse-than-expected Q2 sales results.</li>
<li>Invitae Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvta#NYSE">NVTA</a>) fell 12.7% to $4.38.</li>
<li>E-Home Household Service Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ejh#NASDAQ">EJH</a>) fell 12.7% to $0.2353.</li>
<li>Compass, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/comp#NYSE">COMP</a>) fell 12.4% to $4.10 after the company reported worse-than-expected Q2 EPS and sales results and issued Q3 and FY22 sales guidance below estimates.</li>
<li>Cinedigm Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cidm#NASDAQ">CIDM</a>) fell 11.4% to $0.6750 after posting a loss for the first quarter.</li>
<li>AMTD Digital Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hkd#NYSE">HKD</a>) dropped 11.2% to $171.00. AMTD Group will inject into AMTD IDEA Group 100% of the equity interest in AMTD Assets Group.</li>
<li>Vislink Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/visl#NASDAQ">VISL</a>) fell 11.1% to $0.6022 after reporting a wider quarterly loss.</li>
<li>Bloom Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/be#NYSE">BE</a>) dropped 11.1% to $26.98 after the company announced the commencement of a public offering of 13 million shares.</li>
<li>Arcimoto, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fuv#NASDAQ">FUV</a>) fell 11% to $2.7150 following weak Q2 results. Arcimoto also said due to uncertainty caused by supply chain headwinds co. will not meet prior FY production guidance.</li>
<li>BuzzFeed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzfd#NASDAQ">BZFD</a>) dropped 10.6% to $1.9401.</li>
<li>Super Group (SGHC) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sghc#NYSE">SGHC</a>) fell 9.4% to $4.9850.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) dipped 9.3% to $27.02 after the company announced a proposed private offering of $425 million of convertible senior notes.</li>
<li>AMN Healthcare Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amn#NYSE">AMN</a>) dropped 7.3% to $103.93.</li>
<li>ZipRecruiter, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zip#NYSE">ZIP</a>) fell 7.2% to $19.46 after the company reported Q2 earnings results.</li>
<li>Trinity Capital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trin#NASDAQ">TRIN</a>) fell 7.1% to $15.13 after the company reported pricing of $55.0 million of shares in upsized offering of common stock.</li>
</ul>

Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session

CEMI

Ten Stocks Trending on Discord for Tuesday August 16, 2022: BBBY, ARTL, HLBZ, WMT, CEMI, MYSZ, GBOX, GIGM, VEEE, DNA

<ul>
<li>
Kohl&#39;s (KSS) - A play on upcoming earnings. The company will report quarterly results on Thursday before market open. Reminder: Kohl&#39;s was recently the target of a takeover approach but the talks with Franchise Group (FRG) were abandoned.
</li>
</ul>
<ul>
<li>
XpresSpa (XSPA) - Shares were trending on communication platform Discord recently. On Monday, the company won a contract to expand the Center for Disease Control&#39;s (CDC) traveler-based SARS-CoV-2 genomic surveillance program in US airports.
</li>
</ul>
<ul>
<li>
Genius Sports (GENI) - A niche way to play sports betting. Analysts at Needham commented favorably on the company Tuesday morning following Genius quarterly results. Needham believes Genius &quot;plays a crucial role in the sports betting process facilitating the transfer of data from sports leagues to sports books and should benefit from the rising tide of sports betting globally.&quot;
</li>
</ul>
<ul>
<li>
GigaMedia (GIGM) - Highlighted in one of <a href="http://pro.benzinga.com">Benzinga Pro</a>&#39;s <a href="https://pro.benzinga.com/popout/widget/stream/4JnCRpcVw">chat rooms</a> as &quot;getting pushed by a room.&quot; Shares closed up more than 40% on Monday and were up another 15% Tuesday morning despite no news. Tune into Benzinga&#39;s daily Stocks To Watch podcast (around 9:30 a.m. EDT on <a href="https://twitter.com/Benzinga?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor">Twitter</a> or on <a href="https://www.benzinga.com/money/podcast-show/daily-stocks-to-watch">Spotify</a> after 10:30 a.m.) to hear more insight on what &quot;pushed by a room&quot; means and why this perspective is important.
</li>
</ul>
<ul>
<li>
Velo3D (VLD) - A potential sympathy play following news American Air (AAL) signed an agreement to buy Overture aircrafts from Boom Supersonic. Velo3D is a manufacturing partner for Boom. Shares of Velo3D have been known to move on news related to Boom Supersonic.
</li>
</ul>

GENI

XSPA

Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Aug. 16, 2022: KSS, XSPA, GENI, GIGM, VLD

<h3>Gainers</h3>
<ul>
<li>IZEA Worldwide, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izea#NASDAQ">IZEA</a>) shares rose 30.8% to $1.19 in pre-market trading after the company reported a second-quarter revenue increase of 96% year-over-year to $12.58 million, beating the consensus of $9.75 million.</li>
<li>GreenBox POS (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbox#NASDAQ">GBOX</a>) shares rose 29.9% to $1.65 in pre-market trading as the company reported better-than-expected Q2 sales.</li>
<li>TransGlobe Energy Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tga#NASDAQ">TGA</a>) rose 20% to $3.96 in pre-market trading after declining 4% on Monday.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dna#NYSE">DNA</a>) shares rose 17.5% to $4.10 in pre-market trading after the company said Q2 sales results were up year over year and raised FY22 sales guidance above estimates.</li>
<li>Mainz Biomed B.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mynz#NASDAQ">MYNZ</a>) rose 16.3% to $10.80 in pre-market trading. Mainz Biomed and Dante Genomics announced full commercial availability of ColoAlert in Italy and the United Arab Emirates.</li>
<li>Energy Services of America Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/esoa#NASDAQ">ESOA</a>) rose 15.6% to $2.75 in pre-market trading. Energy Services Of America posted Q2 earnings of $0.10 per share on sales of $51.17 million.</li>
<li>Forza X1, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frza#NASDAQ">FRZA</a>) rose 13.4% to $6.87 in pre-market trading after declining 19% on Monday.</li>
<li>AIM ImmunoTech Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aim#NYSE">AIM</a>) rose 13.1% to $0.8880 in pre-market trading. The company issued an update on Jorgl activist group litigation. AIM ImmunoTech, on Monday, posted a Q2 loss of $0.10 per share.</li>
<li>GigaMedia Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gigm#NASDAQ">GIGM</a>) rose 12.9% to $2.62 in pre-market trading after jumping over 41% on Monday. GigaMedia, last month, posted a Q2 loss of $0.10 per share.</li>
<li>Treasure Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgl#NASDAQ">TGL</a>) shares rose 12.8% to $8.12 in pre-market trading after the company reported closing of upsized $9.2 million initial public offering, Nasdaq listing, and full exercise of underwriter&rsquo;s over-allotment option.</li>
<li>Embark Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/embk#NASDAQ">EMBK</a>) rose 12.6% to $0.8259 in pre-market trading after dropping around 32% on Monday. Embark Technology, last week, reported better-than-expected Q2 EPS results.</li>
<li>OKYO Pharma Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okyo#NASDAQ">OKYO</a>) rose 11.8% to $2.37 in pre-market trading after reporting its final audited results for the year ended 31 March 2022.</li>
<li>Nu Holdings Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nu#NYSE">NU</a>) rose 11.3% to $5.21 in pre-market trading following strong quarterly sales.</li>
<li>Magic Empire Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/megl#NASDAQ">MEGL</a>) shares rose 10.1% to $19.52 in pre-market trading. Magic Empire shares jumped over 115% on Monday on volatility following the company&#39;s IPO earlier this month.</li>
<li>Uxin Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uxin#NASDAQ">UXIN</a>) rose 9.4% to $0.6776 in pre-market trading. The company, last month, posted a profit for the fourth quarter.</li>
<li>Unity Biotechnology, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ubx#NASDAQ">UBX</a>) rose 9.2% to $1.41 in pre-market trading. UNITY Biotechnology recently disclosed positive 12 and 18-week data from its Phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema (DME).</li>
<li>Senmiao Technology Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aihs#NASDAQ">AIHS</a>) rose 8.9% to $1.10 in pre-market trading after the company posted a profit for the first quarter.</li>
<li>Kaspien Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kspn#NASDAQ">KSPN</a>) rose 8.1% to $3.49 in pre-market trading after declining around 4% on Monday.</li>
<li>IonQ, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ionq#NYSE">IONQ</a>) rose 6.5% to $6.77 in pre-market trading following upbeat Q2 sales.</li>
</ul>

Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>.
<h3>Losers</h3>
<ul>
<li>Save Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svfd#NASDAQ">SVFD</a>) shares fell 31.9% to $3.24 in pre-market trading after the company reported the pricing of a public offering of 1,600,000 shares at $3.00 per share.</li>
<li>T2 Biosystems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttoo#NASDAQ">TTOO</a>) shares fell 20.7% to $0.1628 in pre-market trading after the company reported a wider Q2 loss and announced worse-than-expected sales results.</li>
<li>Hallmark Financial Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hall#NASDAQ">HALL</a>) fell 17.7% to $2.05 in pre-market trading after the company posted a wider quarterly loss.</li>
<li>iSun, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/isun#NASDAQ">ISUN</a>) fell 17.7% to $4.02 in pre-market trading as the company posted a wider loss for its second quarter.</li>
<li>Polished.com Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pol#NYSE">POL</a>) fell 14.6% to $1.29 in pre-market trading. Polished.com said it sees preliminary Q2 sales of $145 million to $150 million, versus analysts&rsquo; estimates of $156.15 million.</li>
<li>Tremor International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trmr#NASDAQ">TRMR</a>) fell 14.1% to $8.94 in pre-market trading after declining around 5% on Monday.</li>
<li>GAN Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gan#NASDAQ">GAN</a>) fell 13.6% to $3.75 in pre-market trading after the company reported worse-than-expected Q2 sales results and issued FY22 sales guidance below estimates.</li>
<li>MiNK Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inkt#NASDAQ">INKT</a>) fell 12.1% to $2.99 in pre-market trading after gaining 99% on Monday.</li>
<li>E-Home Household Service Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ejh#NASDAQ">EJH</a>) fell 10.8% to $0.24 in pre-market trading.</li>
<li>AST SpaceMobile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asts#NASDAQ">ASTS</a>) fell 10% to $11.48 in pre-market trading after reporting Q2 results.</li>
<li>Vislink Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/visl#NASDAQ">VISL</a>) fell 9.5% to $0.62 in pre-market trading after reporting a wider quarterly loss.</li>
<li>Remark Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mark#NASDAQ">MARK</a>) shares fell 9.3% to $0.49 in pre-market trading after posting downbeat quarterly sales.</li>
<li>Helbiz, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlbz#NASDAQ">HLBZ</a>) fell 9.1% to $1.30 in pre-market trading. Helbiz posted a Q2 loss of $0.57 per share.</li>
<li>Trinity Capital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trin#NASDAQ">TRIN</a>) fell 8.6% to $14.88 in pre-market trading after the company reported pricing of $55.0 million of shares in upsized offering of common stock.</li>
<li>Arcimoto, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fuv#NASDAQ">FUV</a>) fell 7.9% to $2.81 in pre-market trading following weak Q2 results. Arcimoto also said due to uncertainty caused by supply chain headwinds co. will not meet prior FY production guidance.</li>
<li>Cinedigm Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cidm#NASDAQ">CIDM</a>) fell 7.4% to $0.7068 in pre-market trading after posting a loss for the first quarter.</li>
<li>Sema4 Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfr#NASDAQ">SMFR</a>) fell 6.3% to $2.25 in pre-market trading after the company reported a drop in Q2 sales and issued weak FY22 sales forecast.</li>
<li>GoHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goco#NASDAQ">GOCO</a>) shares fell 6.2% to $0.8290 in pre-market trading following downbeat quarterly earnings.</li>
</ul>

<h3>Gainers</h3>
<ul>
<li>Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New Energy effective as of August 10, 2022.</li>
<li>Magic Empire Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/megl#NASDAQ">MEGL</a>) shares climbed 80.9% to $14.87 on volatility following the company&#39;s IPO earlier this month.</li>
<li>Viridian Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrdn#NASDAQ">VRDN</a>) surged 57.7% to $23.23 after the company reported better-than-expected Q2 sales results. The company also announced initial data from the 10mg/kg cohort in its ongoing Phase 1/2 trial of VRDN-001 for thyroid eye disease (TED), a rare autoimmune disease in which the body&#39;s immune system attacks the tissues around and behind the eyes.</li>
<li>Plus Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstv#NASDAQ">PSTV</a>) shares jumped 51.7% to $0.8010 as the company presented positive data from ongoing ReSPECT&trade; clinical trials at the Annual Conference on CNS Clinical Trials and Brain Metastases.</li>
<li>Team, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tisi#NYSE">TISI</a>) gained 47.7% to $1.45 after the company announced the sale of its Quest Integrity business to Baker Hughes for $280 million cash. The company also reported Q2 EPS and sales results were up year over year.</li>
<li>Regis Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rgs#NYSE">RGS</a>) jumped 46% to $1.0610 after the company announced it has amended its credit facility and extended the maturity date from March 23, 2023 to August 31, 2025.</li>
<li>GigaMedia Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gigm#NASDAQ">GIGM</a>) gained 41.6% to $2.32. GigaMedia recently posted a Q2 loss of $0.10 per share.</li>
<li>Liberty TripAdvisor Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltrpb#NASDAQ">LTRPB</a>) jumped 37.2% to $37.08.</li>
<li>Intelligent Living Application Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilag#NASDAQ">ILAG</a>) gained 37.1% to $3.73.</li>
<li>Tuesday Morning Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tuem#NASDAQ">TUEM</a>) rose 28% to $0.3548 after declining around 5% on Friday.</li>
<li>Accelerate Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axdx#NASDAQ">AXDX</a>) gained 25% to $2.6599 after the company announced a global commercial collaboration agreement with BD. The company also reported better-than-expected Q2 earnings results.</li>
<li>TherapeuticsMD, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/txmd#NASDAQ">TXMD</a>) gained 22.2% to $11.25 after the company reported a profit for the second quarter and also announced better-than-expected sales results.</li>
<li>Osisko Development Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/odv#NYSE">ODV</a>) jumped 21% to $7.36. Osisko Development reported cash position of approximately C$136.3 million as of June 30, 2022.</li>
<li>InVivo Therapeutics Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nviv#NASDAQ">NVIV</a>) gained 19.7% to $9.71.</li>
<li>Blue Apron Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aprn#NYSE">APRN</a>) surged 17.5% to $4.4785. Lake Street initiated coverage on Blue Apron) with a Buy rating and announced a price target of $9.</li>
<li>Alaunos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) jumped 17% to $1.9400 after the company reported better-than-expected Q2 EPS results.</li>
<li>Studio City International Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msc#NYSE">MSC</a>) gained 16.8% to $1.9740.</li>
<li>Enhabit, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ehab#NYSE">EHAB</a>) surged 15.9% to $16.03. Enhabit recently reported a 6.3% year-over-year decline in net service revenue.</li>
<li>DouYu International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/doyu#NASDAQ">DOYU</a>) gained 15.8% to $1.4484. DouYu International reported a second-quarter FY22 revenue decline of 21.6% to $273.7 million year-on-year, beating the consensus of 263.99 million.</li>
<li>Embecta Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/embc#NASDAQ">EMBC</a>) gained 15.2% to $33.04. Embecta reported better-than-expected Q3 EPS and sales results.</li>
<li>FlexShopper, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fpay#NASDAQ">FPAY</a>) jumped 14.6% to $2.12. FlexShopper, last week, reported Q2 results.</li>
<li>ironSource Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/is#NYSE">IS</a>) gained 14.4% to $4.59 after Unity&#39;s board of directors reaffirmed its commitment to the transaction with ironSource and rejected the unsolicited proposal from AppLovin.</li>
<li>Synaptogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpx#NASDAQ">SNPX</a>) gained 13.8% to $8.45.</li>
<li>Rhythm Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rytm#NASDAQ">RYTM</a>) gained 13.5% to $24.75. Goldman Sachs recently upgraded the stock from Neutral to Buy.</li>
<li>HeartCore Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htcr#NASDAQ">HTCR</a>) surged 12.6% to $2.7803. HeartCore Enterprises posted a Q2 loss of $0.09 per share.</li>
<li>Poshmark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/posh#NASDAQ">POSH</a>) gained 12.5% to $13.28 after Barclays upgraded the stock from Equal-Weight to Overweight and announced a price target of $17.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) gained 12.4% to $1.91.</li>
<li>RVL Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvlp#NASDAQ">RVLP</a>) gained 12.4% to $2.2250.</li>
<li>Westwater Resources, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wwr#NYSE">WWR</a>) jumped 12% to $1.64. Westwater Resources recently posted Q2 loss of $0.07 per share.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) rose 11.1% to $23.05.</li>
<li>Genprex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnpx#NASDAQ">GNPX</a>) gained 11% to $1.9650. Genprex said Safety Review Committee approved dose escalation in Acclaim-1 Phase 1/2 trial of REQORSA in combination with tagrisso in non-small cell lung cancer.</li>
<li>XP Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xp#NASDAQ">XP</a>) gained 11% to $21.89. JP Morgan recently downgraded the stock from Overweight to Neutral.</li>
<li>Westwater Resources, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wwr#NYSE">WWR</a>) rose 10.2% to $0.37. Westwater Resources recently posted a Q2 loss of $0.07 per share.</li>
<li>AST SpaceMobile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asts#NASDAQ">ASTS</a>) gained 10.1% to $12.80. The company recently announced that its test satellite has arrived at the launch location for its upcoming planned launch.</li>
<li>Illumina, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilmn#NASDAQ">ILMN</a>) jumped 9.6% to $228.27. Morgan Stanley maintained Illumina with an Equal-Weight and lowered the price target from $350 to $240.</li>
<li>NuZee, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nuze#NASDAQ">NUZE</a>) rose 9.3% to $0.8197. NuZee recently announced closing of $3.4 million underwritten public offering of common stock.</li>
<li>Performance Shipping Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pshg#NASDAQ">PSHG</a>) shares rose 8.8% to $0.37. Performance Shipping shares dipped around 45% on Friday after the company priced its 33 million share offering at $0.45 per share.</li>
<li>Bed Bath &amp; Beyond Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbby#NASDAQ">BBBY</a>) gained 8.2% to $14.01 as the stock regained momentum, which has been driven by retail investor attention on social media.</li>
<li>Twin Vee Powercats Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veee#NASDAQ">VEEE</a>) rose 7% to $7.59 after surging around 78% on Friday. The company reported a 158% surge in net revenue for the three months ended June 30, 2022.</li>
<li>Tilray Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>) gained 6.8% to $4.3050.</li>
<li>Tencent Music Entertainment Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tme#NYSE">TME</a>) gained 6% to $4.6750. Tencent Music Entertainment Group is expected to report its Q2 unaudited financial results after the U.S. market closes on Monday, August 15, 2022.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>IDEAYA Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idya#NASDAQ">IDYA</a>) shares fell 36.9% to $9.88 after the company reported a wider Q2 loss.</li>
<li>Embark Technology, Inc.. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/embk#NASDAQ">EMBK</a>) fell 27.1% to $0.7801. Embark Technology shares jumped 85% on Friday after the company reported better-than-expected Q2 EPS results.</li>
<li>Heliogen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlgn#NASDAQ">HLGN</a>) dropped 22% to $2.36. California Judge proposed 1-year delay for solar subsidy reform.</li>
<li>WeTrade Group, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wetg#NASDAQ">WETG</a>) fell 19.7% to $9.02 after dropping 20% on Friday. WeTrade entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests for $50 million.</li>
<li>Save Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svfd#NASDAQ">SVFD</a>) dipped 19.6% to $4.51.</li>
<li>loanDepot, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ldi#NYSE">LDI</a>) fell 16.4% to $1.7050. The company recently posted downbeat quarterly results.</li>
<li>Nocera, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncra#NASDAQ">NCRA</a>) dipped 16.3% to $2.05.</li>
<li>LogicBio Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/logc#NASDAQ">LOGC</a>) fell 16.1% to $0.5200. LogicBio Therapeutics posted a Q2 loss of $0.15 per share.</li>
<li>Inhibikase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikt#NASDAQ">IKT</a>) dropped 15.3% to $0.7831. Inhibikase Therapeutics reported its Q2 earnings results on Friday.</li>
<li>Sensus Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srts#NASDAQ">SRTS</a>) fell 14.8% to $12.74.</li>
<li>Treasure Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgl#NASDAQ">TGL</a>) fell 14.6% to $7.17. The company recently priced its IPO at $4 per share.</li>
<li>23andMe Holding Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/me#NASDAQ">ME</a>) fell 13.7% to $4.4150. 23andMe recently reported worse-than-expected Q2 EPS results.</li>
<li>AMMO, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/poww#NASDAQ">POWW</a>) fell 13.5% to $5.18 after the company announced plans to separate its ammunition and marketplace businesses into two independent publicly-traded companies.</li>
<li>Immunovant, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imvt#NASDAQ">IMVT</a>) dropped 13.5% to $4.86. The company recently posted a wider Q1 loss.</li>
<li>SmartRent, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smrt#NYSE">SMRT</a>) fell 13.2% to $3.3150. SmartRent recently reported worse-than-expected Q2 EPS and sales results and issued Q3 and FY22 sales guidance below estimates.</li>
<li>Forza X1, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frza#NASDAQ">FRZA</a>) fell 13% to $6.52 after climbing 50% on Friday. The company priced its IPO at $5 per share.</li>
<li>CorpHousing Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chg#NASDAQ">CHG</a>) dropped 12.7% to $3.23.</li>
<li>1847 Holdings LLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efsh#NASDAQ">EFSH</a>) dropped 12.3% to $2.76.</li>
<li>GoHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goco#NASDAQ">GOCO</a>) fell 10.4% to $0.8053.</li>
<li>Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) dipped 10.2% to $0.5990. Dave recently reported worse-than-expected Q2 sales results.</li>
<li>Turquoise Hill Resources Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trq#NYSE">TRQ</a>) shares fell 10.1% to $23.59 after the special committee of independent directors of the company terminated its review and consideration of Rio Tinto&#39;s acquisition proposal.</li>
<li>Cryptyde, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tyde#NASDAQ">TYDE</a>) fell 10.1% to $1.0696 after gaining over 6% on Friday.</li>
<li>GoHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goco#NASDAQ">GOCO</a>) fell 9.9% to $0.8098 after jumping around 42% on Friday.</li>
<li>Astra Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/astr#NASDAQ">ASTR</a>) dipped 9.6% to $1.4550.</li>
<li>Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/csse#NASDAQ">CSSE</a>) fell 9% to $11.10. Chicken Soup For The Soul Entertainment recently reported Q2 adjusted EPS results were down year over year.</li>
<li>Arcadia Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rkda#NASDAQ">RKDA</a>) shares fell 5.7% to $1.0101 after the company reported a $5.0 million registered direct offering priced at-the-market.</li>
</ul>

CSSE

EFSH

Sunrise New Energy Co., Ltd - Ordinary Shares

TXMD

Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>BIMI International Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bimi#NASDAQ">BIMI</a>) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D.</li>
<li>Ontrak, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otrk#NASDAQ">OTRK</a>) shares rose 64.6% to $1.12 in pre-market trading. Ontrak recently reported closing of registered direct offering for aggregate gross proceeds of $4.0 million.</li>
<li>GoodRx Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdrx#NASDAQ">GDRX</a>) rose 44.3% to $11.20 in pre-market trading after the company reported better-than-expected Q2 sales results.</li>
<li>Guardforce AI Co., Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gfai#NASDAQ">GFAI</a>) rose 31.6% to $0.3950 in pre-market trading.</li>
<li>Tuesday Morning Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tuem#NASDAQ">TUEM</a>) rose 29.7% to $0.4668 in pre-market trading after gaining around 68% on Monday.</li>
<li>Verona Pharma plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrna#NASDAQ">VRNA</a>) rose 28.4% to $8.92 in pre-market trading after the company reported Q2 financial results and issued corporate update.</li>
<li>American Virtual Cloud Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avct#NASDAQ">AVCT</a>) rose 23.1% to $0.2050 in pre-market trading.</li>
<li>Sentage Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sntg#NASDAQ">SNTG</a>) shares rose 22% to $0.92 in pre-market trading higher after jumping over 6% on Monday.</li>
<li>Desktop Metal, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dm#NYSE">DM</a>) shares rose 21.6% to $3.15 in pre-market trading after posting better-than-expected Q2 sales.</li>
<li>Lemonade, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lmnd#NYSE">LMND</a>) shares rose 15.5% to $29.00 in pre-market trading after the company reported better-than-expected Q2 results and issued sales guidance above estimates.</li>
<li>GigaMedia Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gigm#NASDAQ">GIGM</a>) rose 13.7% to $1.81 in pre-market trading. The company recently posted a wider quarterly loss.</li>
<li>Helbiz, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlbz#NASDAQ">HLBZ</a>) rose 13% to $1.82 in pre-market trading after jumping 115% on Monday.</li>
<li>Bed Bath &amp; Beyond Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbby#NASDAQ">BBBY</a>) rose 11.3% to $12.70 in pre-market trading. Bed Bath &amp; Beyond shares jumped around 40% on Monday amid significant social media mentions over the weekend.</li>
<li>Seelos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seel#NASDAQ">SEEL</a>) rose 10.5% to $2.72 in pre-market trading after dropping 10% on Monday.</li>
<li>Peraso Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prso#NASDAQ">PRSO</a>) rose 10.4% to $1.80 in pre-market trading. Peraso recently received customer orders totaling $6.4 million for mmWave Fixed Wireless Access market.</li>
<li>Ralph Lauren Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rl#NYSE">RL</a>) rose 8.5% to $109.79 in pre-market trading.</li>
<li>Enovix Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/envx#NASDAQ">ENVX</a>) rose 8.4% to $14.85 in pre-market trading after declining around 5% on Monday. JP Morgan recently initiated coverage on Enovix with an Overweight rating and announced a price target of $20.</li>
<li>AMTD IDEA Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amtd#NYSE">AMTD</a>) rose 7.7% to $3.21 in pre-market trading. AMTD Idea Group shares dropped around 36% on Monday possibly on profit taking after the stock surged over the last few trading days.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>.
<h3>Losers</h3>
<ul>
<li>CorMedix Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmd#NASDAQ">CRMD</a>) shares fell 51.1% to $3.64 in pre-market trading after the company said a second complete response letter from the FDA was received saying DefenCath NDA cannot be approved until certain deficiencies are resolved to satisfaction of FDA.</li>
<li>Aytu BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aytu#NASDAQ">AYTU</a>) shares fell 36.2% to $0.37 in pre-market trading after the company announced the launch of public offering.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) fell 30.7% to $39.70 in pre-market trading after the company reported second-quarter revenue decline of 37.6% year-over-year to $185.9 million. The company also lowered its sales forecast for the year.</li>
<li>Turtle Beach Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hear#NASDAQ">HEAR</a>) shares fell 29.2% to $9.90 in pre-market trading after reporting downbeat second quarter financial results and announced an update to a strategic review.</li>
<li>Eargo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ear#NASDAQ">EAR</a>) fell 21.9% to $1.07 in pre-market trading after the company posted a wider Q2 loss.</li>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) fell 16.7% to $1.14 in pre-market trading after the company reported Q2 results and announced a 1-for-18 reverse stock split.</li>
<li>SOBR Safe, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sobr#NASDAQ">SOBR</a>) fell 15.4% to $1.21 in pre-market trading after gaining 25% on Monday.</li>
<li>Trex Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trex#NYSE">TREX</a>) fell 13.7% to $55.00 in pre-market trading following Q2 results.</li>
<li>23andMe Holding Co (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/me#NASDAQ">ME</a>) fell 12.8% to $3.47 in pre-market trading after the company reported worse-than-expected Q2 EPS results.</li>
<li>CarGurus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/carg#NASDAQ">CARG</a>) fell 12.6% to $22.49 in pre-market trading after the company issued weak forecast for the third quarter.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) shares fell 12.4% to $11.58 in pre-market trading after the company reported a loss for its second quarter and lowered its FY22 sales guidance.</li>
<li>Upstart Holdings, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) fell 12% to $28.40 in pre-market trading after the company reported Q2 results and issued Q3 sales guidance below estimates.</li>
<li>Allbirds, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bird#NASDAQ">BIRD</a>) fell 10.6% to $5.07 in pre-market trading after the company issued Q3 and FY22 sales guidance below estimates.</li>
<li>Cepton, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cptn#NASDAQ">CPTN</a>) fell 10.4% to $1.64 in pre-market trading after the company posted a loss for its second quarter and issued weak sales forecast for FY22.</li>
<li>TOMI Environmental Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tomz#NASDAQ">TOMZ</a>) fell 10.1% to $1.16 in pre-market trading. TOMI Environmental Solutions shares jumped over 29% on Monday after the company highlighted its SteraMist as a disinfectant against the Monkeypox virus.</li>
<li>Clover Health Investments, Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clov#NASDAQ">CLOV</a>) fell 9.7% to $3.07 in pre-market trading after the company reported financial results and reaffirmed full-year guidance.</li>
<li>Aterian, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ater#NASDAQ">ATER</a>) fell 9.7% to $2.69 in pre-market trading as the company reported second-quarter financial results.</li>
<li>bluebird bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blue#NASDAQ">BLUE</a>) fell 9.3% to $5.75 in pre-market trading after jumping 13% on Monday.</li>
<li>Bonso Electronics International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnso#NASDAQ">BNSO</a>) fell 9.1% to $7.16 in pre-market trading after gaining 65% on Monday.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) fell 7.3% to $19.41 in pre-market trading after declining 8% on Monday.</li>
</ul>

ATER

AVCT

AYTU

BIMI

BIRD

BLUE

BNSO

CARG

CLOV

CPTN

CRMD

ENVX

GDRX

GFAI

HEAR

LMND

NVAX

OTRK

PRSO

ROOT

SEEL

SNTG

SOBR

TOMZ

TREX

UPST

VRNA

Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket

GigaMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIGM#NASDAQ">GIGM</a>) reported quarterly losses of $(0.10) per share. This is a 25 percent decrease over losses of $(0.08) per share from the same period last year.

GigaMedia Q2 EPS $(0.10) Down From $(0.08) YoY

<h3>Gainers</h3>
<ul>
<li>Zymeworks Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zyme#NASDAQ">ZYME</a>) rose 40.3% to $6.97 in pre-market trading. Zymeworks 13D filing confirmed earlier reporting of offer letter from Blue Falcons for $10.50 per share.</li>
<li>Finch Therapeutics Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fnch#NASDAQ">FNCH</a>) shares rose 40% to $2.94 in pre-market trading. The U.S. Food and Drug Administration (FDA) removed the clinical hold on Finch Therapeutics Group investigational new drug (IND) application for CP101 in the prevention of recurrent C. difficile infection (CDI).</li>
<li>NewAge, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbev#NASDAQ">NBEV</a>) rose 32.4% to $0.53 in pre-market trading.</li>
<li>JD.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) rose 14.6% to $66.29 in pre-market trading. JD.com filed its annual report on Form 20-F for the fiscal year ended December 31, 2021.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) rose 14.4% to $33.90 in pre-market trading. GDS Holdings filed its annual report on Form 20-F for the fiscal year ended December 31, 2021.</li>
<li>DiDi Global Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/didi#NYSE">DIDI</a>) rose 13.7% to $2.06 in pre-market trading.</li>
<li>Pinduoduo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pdd#NASDAQ">PDD</a>) rose 13.7% to $43.15 in pre-market trading.</li>
<li>Bilibili Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bili#NASDAQ">BILI</a>) rose 13.7% to $25.25 in pre-market trading.</li>
<li>Full Truck Alliance Co. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ymm#NASDAQ">YMM</a>) rose 13.6% to $5.69 in pre-market trading.</li>
<li>Digital World Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dwac#NASDAQ">DWAC</a>) rose 13.1% to $54.34 in pre-market trading after gaining 8% on Thursday.</li>
<li>iQIYI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iq#NASDAQ">IQ</a>) shares rose 12.6% to $3.76 in pre-market trading.</li>
<li>Alibaba Group Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baba#NYSE">BABA</a>) rose 12.2% to $102.00 in pre-market trading. Analysts slashed the earnings estimates for the Chinese technology giants for a second straight month amid the nation&rsquo;s persistent goal of its Covid-Zero strategy, Bloomberg reported. Analysts trimmed Alibaba Group estimates by 4.2%.</li>
<li>KE Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/beke#NASDAQ">BEKE</a>) rose 11.7% to $14.88 in pre-market trading.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) rose 11.5% to $4.15 in pre-market trading after gaining over 6% on Thursday.</li>
<li>Innate Pharma S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipha#NASDAQ">IPHA</a>) rose 10% to $2.97 in pre-market trading after the company said it has dosed first patient in Monalizumab Phase 3 lung cancer clinical trial.</li>
<li>Aurora Mobile Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jg#NASDAQ">JG</a>) rose 7.7% to $0.89 in pre-market trading.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>.
<h3>Losers</h3>
<ul>
<li>Accolade, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/accd#NASDAQ">ACCD</a>) shares fell 37.6% to $6.90 in pre-market trading after the company reported Q4 earnings results and issued Q1 sales guidance below analyst estimates.</li>
<li>Genocea Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnca#NASDAQ">GNCA</a>) fell 24% to $0.31 in pre-market trading after the company announced that it has initiated a process to explore a range of strategic alternatives including the sale of all or part of the company, a merger or a reverse merger.</li>
<li>T Stamp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idai#NASDAQ">IDAI</a>) fell 16.7% to $3.91 in pre-market trading. T Stamp shares jumped around 124% on Thursday after the company announced the launch of its Biometric MFA solution.</li>
<li>Statera Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stab#NASDAQ">STAB</a>) shares fell 16.5% to $0.3173 in pre-market trading. Statera Biopharma shares jumped over 80% on Thursday after the company and Immune Therapeutics announced a strategic agreement for rights to low dose naltrexone.</li>
<li>Evoke Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evok#NASDAQ">EVOK</a>) shares fell 15.7% to $0.42 in pre-market trading after dipping 25% on Thursday.</li>
<li>CooTek (Cayman) Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctk#NYSE">CTK</a>) fell 14% to $0.1885 in pre-market trading after the company announced a plan to implement a 1-to-650 ADS ratio change.</li>
<li>GigaMedia Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gigm#NASDAQ">GIGM</a>) fell 13.6% to $1.51 in pre-market trading. GigaMedia, last month, posted Q4 operating loss of $4 million.</li>
<li>Robinhood Markets, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hood#NASDAQ">HOOD</a>) fell 11.1% to $8.97 in pre-market trading after the company reported worse-than-expected Q1 EPS and sales results. Also, the company said it will no longer provide revenue guidance.</li>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) fell 11% to $1.70 in pre-market trading after jumping over 10% on Thursday.</li>
<li>Tuniu Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tour#NASDAQ">TOUR</a>) fell 9.3% to $0.7020 in pre-market trading after jumping 22% on Thursday.</li>
<li>Amazon.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) shares fell 8.9% to $2,635.97 in pre-market trading. Amazon reported a $3.8 billion net loss for the first quarter, versus a year-ago net income of $8.1 billion. The company also issued weak Q2 sales guidance.</li>
<li>Ra Medical Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rmed#NYSE">RMED</a>) fell 8.6% to $0.3410 in pre-market trading after jumping 26% on Thursday.</li>
</ul>

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

GigaMedia

GigaMedia (GIGM) Forecast

GigaMedia (NASDAQ:GIGM) Stock, Quote.Headers.trade-ideas